Di căn não ở bệnh nhân ung thư phổi: so sánh kết quả sống sót giữa xạ trị não toàn bộ, xạ trị não toàn bộ với tăng cường liên tiếp và xạ trị điều biến cường độ tăng cường tích hợp đồng thời

Andrews DW, Scott CB, Sperduto PW, Flanders AE, Gaspar LE, Schell MC, Werner-Wasik M, Demas W, Ryu J, Bahary JP, Souhami L, Rotman M, Mehta MP, Curran WJ (2004) Whole brain radiation therapy with or without stereotactic radiosurgery boost for patients with one to three brain metastases: phase III results of the RTOG 9508 randomised trial. Lancet 363:1665–1672 Borghetti P, Pedretti S, Spiazzi L, Avitabile R, Urpis M, Foscarini F, Tesini G, Trevisan F, Ghirardelli P, Pandini SA, Triggiani L, Magrini SM, Buglione M (2016) Whole brain radiotherapy with adjuvant or concomitant boost in brain metastasis: dosimetric comparison between helical and volumetric IMRT technique. Radiat Oncol 11:59 Brown PD, Jaeckle K, Ballman KV, Farace E, Cerhan JH, Anderson SK, Carrero XW, Barker FG, Deming R, Burri SH, Ménard C, Chung C, Stieber VW, Pollock BE, Galanis E, Buckner JC, Asher AL (2016) Effect of radiosurgery alone vs radiosurgery with whole brain radiation therapy on cognitive function in patients with 1 to 3 brain metastases: a randomized clinical trial. JAMA 316:401–409 Cross DA, Ashton SE, Ghiorghiu S, Eberlein C, Nebhan CA, Spitzler PJ et al (2014) AZD9291, an irreversible EGFR TKI, overcomes T790M-mediated resistance to EGFR inhibitors in lung cancer. Cancer Discov 4(9):1046–1061. https://doi.org/10.1158/2159-8290.CD-14-0337 Dobi Á, Fodor E, Maráz A, Együd Z, Cserháti A, Tiszlavicz L, Reisz Z, Barzó P, Varga Z, Hideghéty K (2020) Boost irradiation integrated to whole brain radiotherapy in the management of brain metastases. Pathol Oncol Res 26(1):149–157 Ferro M, Chiesa S, Macchia G, Cilla S, Bertini F, Frezza G, Farioli A, Cammelli S, Balducci M, Ianiro A, Angelini AL, Compagnone G, Valentini V, Deodato F, Morganti AG (2017) Intensity modulated radiation therapy with simultaneous integrated boost in patients with brain oligometastases: a phase 1 study (ISIDE-BM-1). Int J Radiat Oncol Biol Phys 97:82–90 Gaspar L, Scott C, Rotman M, Asbell S, Phillips T, Wasserman T, McKenna WG, Byhardt R (1997) Recursive partitioning analysis (RPA) of prognostic factors in three Radiation Therapy Oncology Group (RTOG) brain metastases trials. Int J Radiat Oncol Biol Phys 37:745–751 Gaspar LE, Scott C, Murray K, Curran W (2000) Validation of the RTOG recursive partitioning analysis (RPA) classification for brain metastases. Int J Radiat Oncol Biol Phys 47:1001–1006 Giaj Levra N, Sicignano G, Fiorentino A, Fersino S, Ricchetti F, Mazzola R, Naccarato S, Ruggieri R, Alongi F (2016) Whole brain radiotherapy with hippocampal avoidance and simultaneous integrated boost for brain metastases: a dosimetric volumetric-modulated arc therapy study. Radiol Med 121:60–69 Iuchi T, Shingyoji M, Sakaida T, Hatano K, Nagano O, Itakura M et al (2013) Phase II trial of gefitinib alone without radiation therapy for Japanese patients with brain metastases from EGFR-mutant lung adenocarcinoma. Lung Cancer 82(2):282–287. https://doi.org/10.1016/j.lungcan.2013.08.016 Lohmann P, Galldiks N, Kocher M, Heinzel A, Filss CP, Stegmayr C et al (2020a) Radiomics in neuro-oncology: basics, workflow, and applications. Methods. https://doi.org/10.1016/j.ymeth.2020.06.003 Lohmann P, Kocher M, Ruge MI, Visser-Vandewalle V, Shah NJ, Fink GR et al (2020b) PET/MRI Radiomics in patients with brain metastases. Front Neurol 11:1. https://doi.org/10.3389/fneur.2020.00001 Mok TS, Y-L W, M-J A, Garassino MC, Kim HR, Ramalingam SS, et al (2017) Osimertinib or platinum-pemetrexed in EGFR T790M-positive lung cancer. N Engl J Med 376(7):629–640. https://doi.org/10.1056/NEJMoa1612674 Muacevic A, Wowra B, Siefert A, Tonn JC, Steiger HJ, Kreth FW (2008) Microsurgery plus whole brain irradiation versus Gamma Knife surgery alone for treatment of single metastases to the brain: a randomized controlled multicentre phase III trial. J Neurooncol 87:299–307 Nishio M, Nakagawa K, Mitsudomi T, Yamamoto N, Tanaka T, Kuriki H et al (2018) Analysis of central nervous system efficacy in the J-ALEX study of alectinib versus crizotinib in ALK-positive non-small-cell lung cancer. Lung Cancer 121:37–40. https://doi.org/10.1016/j.lungcan.2018.04.015 Oehlke O, Wucherpfennig D, Fels F, Frings L, Egger K, Weyerbrock A, Prokic V, Nieder C, Grosu AL (2015) Whole brain irradiation with hippocampal sparing and dose escalation on multiple brain metastases: local tumour control and survival. Strahlenther Onkol 191:461–469 Preusser M, Winkler F, Valiente M, Manegold C, Moyal E, Widhalm G, Tonn JC, Zielinski C (2018) Recent advances in the biology and treatment of brain metastases of non-small cell lung cancer: summary of a multidisciplinary roundtable discussion. ESMO Open 3:e000262 Routman DM, Bian SX, Diao K, Liu JL, Yu C, Ye J, Zada G, Chang EL (2018) The growing importance of lesion volume as a prognostic factor in patients with multiple brain metastases treated with stereotactic radiosurgery. Cancer Med 7:757–764 Siegel RL, Miller KD, Jemal A (2018) Cancer statistics, 2018. CA Cancer J Clin 68:7–30 Smith DR, Bian Y, Wu CC, Saraf A, Tai CH, Nanda T, Yaeh A, Lapa ME, Andrews J, Cheng SK, McKhann GM, Sisti MB, Bruce JN, Wang T (2019) Natural history, clinical course and predictors of interval time from initial diagnosis to development of subsequent NSCLC brain metastases. J Neurooncol 143:145–155 Sperduto PW, Berkey B, Gaspar LE, Mehta M, Curran W (2008) A new prognostic index and comparison to three other indices for patients with brain metastases: an analysis of 1,960 patients in the RTOG database. Int J Radiat Oncol Biol Phys 70:510–514 Sperduto PW, Kased N, Roberge D, Xu Z, Shanley R, Luo X, Sneed PK, Chao ST, Weil RJ, Suh J, Bhatt A, Jensen AW, Brown PD, Shih HA, Kirkpatrick J, Gaspar LE, Fiveash JB, Chiang V, Knisely JP, Sperduto CM, Lin N, Mehta M (2012) Summary report on the graded prognostic assessment: an accurate and facile diagnosis-specific tool to estimate survival for patients with brain metastases. J Clin Oncol 30:419–425 Sperduto PW, Shanley R, Luo X, Andrews D, Werner-Wasik M, Valicenti R, Bahary JP, Souhami L, Won M, Mehta M (2014) Secondary analysis of RTOG 9508, a phase 3 randomized trial of whole-brain radiation therapy versus WBRT plus stereotactic radiosurgery in patients with 1–3 brain metastases; poststratified by the graded prognostic assessment (GPA). Int J Radiat Oncol Biol Phys 90:526–531 Sperduto PW, Yang TJ, Beal K, Pan H, Brown PD, Bangdiwala A, Shanley R, Yeh N, Gaspar LE, Braunstein S, Sneed P, Boyle J, Kirkpatrick JP, Mak KS, Shih HA, Engelman A, Roberge D, Arvold ND, Alexander B, Awad MM, Contessa J, Chiang V, Hardie J, Ma D, Lou E, Sperduto W, Mehta MP (2017) Estimating survival in patients with lung cancer and brain metastases: an update of the graded prognostic assessment for lung cancer using molecular markers (Lung-molGPA). JAMA Oncol 3:827–831 Tiwari V, Pande SC, Verma K, Goel S (2015) Simultaneous integrated boost with intensity modulated radiation therapy in brain oligometastases: a feasible technique for developing countries. South Asian J Cancer 4:11–14 Tsakonas G, Hellman F, Gubanski M, Friesland S, Tendler S, Lewensohn R, Ekman S, de Petris L (2018) Prognostic factors affecting survival after whole brain radiotherapy in patients with brain metastasized lung cancer. Acta Oncol 57:231–238 Videtic GM, Adelstein DJ, Mekhail TM, Rice TW, Stevens GH, Lee SY, Suh JH (2007) Validation of the RTOG recursive partitioning analysis (RPA) classification for small-cell lung cancer-only brain metastases. Int J Radiat Oncol Biol Phys 67:240–243 Wu YL, Zhou C, Liam CK, Wu G, Liu X, Zhong Z et al (2015) First-line erlotinib versus gemcitabine/cisplatin in patients with advanced EGFR mutation-positive non-small-cell lung cancer: analyses from the phase III, randomized, open-label ENSURE study. Ann Oncol 26(9):1883–1889. https://doi.org/10.1093/annonc/mdv270 Yamamoto M, Serizawa T, Higuchi Y, Sato Y, Kawagishi J, Yamanaka K, Shuto T, Akabane A, Jokura H, Yomo S, Nagano O, Aoyama H (2017) A Multi-institutional prospective observational study of stereotactic radiosurgery for patients with multiple brain metastases (JLGK0901 Study Update): irradiation-related complications and long-term maintenance of Mini-Mental State Examination Scores. Int J Radiat Oncol Biol Phys 99:31–40 Yang J, Zhan W, Zhang H, Song T, Jia Y, Xu H, Lin B, Lv S, Liang X (2017) Intensity-modulated radiation therapy for patients with 1 to 3 brain metastases in recursive partitioning analysis class 3. Medicine (Baltimore) 96:e7715